Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance
Shun Li,Ying Song,Christine Quach,Hongrui Guo,Gyu-Beom Jang,Hadi Maazi,Shihui Zhao,Nathaniel A. Sands,Qingsong Liu,Gino K. In,David Peng,Weiming Yuan,Keigo Machida,Min Yu,Omid Akbari,Ashley Hagiya,Yongfei Yang,Vasu Punj,Liling Tang,Chengyu Liang
DOI: https://doi.org/10.1038/s41467-019-09634-8
IF: 16.6
2019-01-01
Nature Communications
Abstract:Autophagy maintains homeostasis and is induced upon stress. Yet, its mechanistic interaction with oncogenic signaling remains elusive. Here, we show that in BRAF V600E -melanoma, autophagy is induced by BRAF inhibitor (BRAFi), as part of a transcriptional program coordinating lysosome biogenesis/function, mediated by the TFEB transcription factor. TFEB is phosphorylated and thus inactivated by BRAF V600E via its downstream ERK independently of mTORC1. BRAFi disrupts TFEB phosphorylation, allowing its nuclear translocation, which is synergized by increased phosphorylation/inactivation of the ZKSCAN3 transcriptional repressor by JNK2/p38-MAPK. Blockade of BRAFi-induced transcriptional activation of autophagy-lysosomal function in melanoma xenografts causes enhanced tumor progression, EMT-transdifferentiation, metastatic dissemination, and chemoresistance, which is associated with elevated TGF-β levels and enhanced TGF-β signaling. Inhibition of TGF-β signaling restores tumor differentiation and drug responsiveness in melanoma cells. Thus, the “BRAF-TFEB-autophagy-lysosome” axis represents an intrinsic regulatory pathway in BRAF-mutant melanoma, coupling BRAF signaling with TGF-β signaling to drive tumor progression and chemoresistance.